1. Kobau R, Price PH, Giles HW, Pennell PB, Hargis E. Centers for disease control and prevention managing epilepsy well network. Epilepsy Behav [Editorial]. 2010;19(3):216–7.
2. •• Institute of Medicine (U.S.). Committee on the Public Health Dimensions of the Epilepsies., England MJ. Epilepsy across the spectrum : promoting health and understanding. Washington, D.C.: National Academies Press; 2012. This Institute of Medicine report is the authority on managing the entire well- being of a person with epilepsy and addresses gaps in care and social support. It is the road map for how the care of persons with epilepsy needs to evolve in the coming years.
3. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314–9.
4. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE Commission on therapeutic strategies. Epilepsia [Research Support, Non-US Gov't]. 2010;51(6):1069–77.
5. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med [Clinical Trial Comparative Study Randomized Controlled Trial Research Support, Non-US Gov't]. 2001;345(5):311–8.